Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
hydrochlorothiazide, Quantity: 12.5 mg; valsartan, Quantity: 80 mg
Alphapharm Pty Ltd
Hydrochlorothiazide,Valsartan
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; crospovidone; colloidal anhydrous silica; pregelatinised maize starch; sodium lauryl sulfate; lactose monohydrate; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow; iron oxide red
Oral
14, 56, 28, 7, 30
(S4) Prescription Only Medicine
Dilart?HCT is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.
Visual Identification: A light orange, film-coated, oval, biconvex tablet debossed with VH 1 on one side of the tablet and M on other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-08-26
DILART HCT _Valsartan and hydrochlorothiazide_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about DILART HCT. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP TO DATE INFORMATION ON THE MEDICINE. Those updates may contain important information about the medicine and its use of which you should be aware All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DILART HCT IS USED FOR DILART HCT is used to control high blood pressure, also called hypertension. Everybody has blood pressure. This pressure helps get your blood all around your body. Your blood pressure may be different at different times of the day, depending on how busy or worried you are. You have hypertension (high blood pressure) when your blood pressure stays higher than is needed, even when you are calm and relaxed. High blood pressure increases the workload of the heart and blood vessels. If it continues for a long time, it can damage the blood vessels in the brain, heart and kidneys. This can lead to stroke, heart failure or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure reduces the chance of these disorders happening. DILART HCT contains valsartan and hydrochlorothiazide. These medicines reduce blood pressure in two different ways. Valsartan blocks the effect of angiotensin II, which is a substance in the body that tightens blood vessels and makes your blood pressure rise. When the effect of Διαβάστε το πλήρες έγγραφο
AUSTRALIAN PRODUCT INFORMATION DILART HCT _Valsartan and Hydrochlorothiazide Film-Coated Tablets _ 1 NAME OF THE MEDICINE Valsartan Hydrochlorothiazide 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Dilart HCT is available in five strengths: Dilart HCT 80/12.5, Dilart HCT 160/12.5 Dilart HCT 160/25, Dilart HCT 320/12.5 and Dilart HCT 320/25. Dilart HCT 80/12.5 contains valsartan 80 mg and hydrochlorothiazide 12.5 mg; Dilart HCT 160/12.5 contains valsartan 160 mg and hydrochlorothiazide 12.5 mg; Dilart HCT 160/25 contains valsartan 160 mg and hydrochlorothiazide 25 mg; Dilart HCT 320/12.5 contains valsartan 320 mg and hydrochlorothiazide 12.5 mg; Dilart HCT 320/25 contains valsartan 320 mg and hydrochlorothiazide 25 mg. Excipient with known effects: DILART HCT also contains sugars (as lactose). For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM Dilart HCT 80/12.5 : A light orange, film-coated, oval, biconvex tablet debossed with VH 1 on one side of the tablet and M on other side. Dilart HCT 160/12.5 : A reddish, film-coated, oval, biconvex tablet debossed with VH 2 on one side of the tablet and M on other side. Dilart HCT 160/25 : A brown, film-coated, oval, biconvex tablet debossed with VH 3 on one side of the tablet and M on other side. Dilart HCT 320/12.5 : A pink, film-coated, oval, biconvex tablet debossed with VH 4 on one side of the tablet and M on other side. Dilart HCT 320/25 : A yellow, film-coated, oval, biconvex tablet debossed with VH 5 on one side of the tablet and M on other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dilart HCT is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations. 4.2 DOSE AND METHOD OF ADMINISTRATION The recommended dose of Dilart HCT is one tablet per day. When clinically appropriate either Dilart HCT 80/12.5,160/12.5 or 320/12.5 may be used. Dilart HCT 160/12.5 mg may be administered in patients whose blood pressure is not adequately controlled after 4 weeks of treatment by vals Διαβάστε το πλήρες έγγραφο